Jim Simons Hillstream Bio Pharma Inc. Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
$0.34 - $1.89 $4,828 - $26,838
14,200 Added 54.2%
40,400 $32,000
Q4 2022

Feb 13, 2023
BUY
$0.32 - $0.61 $8,384 - $15,982
26,200 New
26,200 $10,000
Q2 2022

Aug 12, 2022
BUY
$0.67 - $1.51 $7,638 - $17,214
11,400 New
11,400 $9,000

About Hillstream BioPharma Inc.

HILS Quotes by TradingView
  • Ticker HILS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,529,900
  • Market Cap $33.2M
  • Description
  • Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) for the treatment resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-888, a ...
More about HILS
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email